Synopsis
0
EU WC
0
KDMF
0
VMF
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]CEP/COS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDA Orange Book
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Related Excipient Companies
SPI Pharma
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pfanstiehl
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Kerry
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Roquette
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Shanghai Hegeng Industrial Co. Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Shijiazhuang Huaxu Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Direct Compression
Chewable & Orodispersible Aids
Parenteral
Co-Processed Excipients
Granulation
Taste Masking
Coating Systems & Additives
Controlled & Modified Release
Thickeners and Stabilizers
Fillers, Diluents & Binders
Digital Content
NEWS #PharmaBuzz
Global Sales Information
US Medicaid Prescriptions
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
78
PharmaCompass offers a list of Lactulose API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Lactulose manufacturer or Lactulose supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Lactulose manufacturer or Lactulose supplier.
PharmaCompass also assists you with knowing the Lactulose API Price utilized in the formulation of products. Lactulose API Price is not always fixed or binding as the Lactulose Price is obtained through a variety of data sources. The Lactulose Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A D-Lactulose manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of D-Lactulose, including repackagers and relabelers. The FDA regulates D-Lactulose manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. D-Lactulose API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of D-Lactulose manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A D-Lactulose supplier is an individual or a company that provides D-Lactulose active pharmaceutical ingredient (API) or D-Lactulose finished formulations upon request. The D-Lactulose suppliers may include D-Lactulose API manufacturers, exporters, distributors and traders.
click here to find a list of D-Lactulose suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A D-Lactulose DMF (Drug Master File) is a document detailing the whole manufacturing process of D-Lactulose active pharmaceutical ingredient (API) in detail. Different forms of D-Lactulose DMFs exist exist since differing nations have different regulations, such as D-Lactulose USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A D-Lactulose DMF submitted to regulatory agencies in the US is known as a USDMF. D-Lactulose USDMF includes data on D-Lactulose's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The D-Lactulose USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of D-Lactulose suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The D-Lactulose Drug Master File in Japan (D-Lactulose JDMF) empowers D-Lactulose API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the D-Lactulose JDMF during the approval evaluation for pharmaceutical products. At the time of D-Lactulose JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of D-Lactulose suppliers with JDMF on PharmaCompass.
A D-Lactulose CEP of the European Pharmacopoeia monograph is often referred to as a D-Lactulose Certificate of Suitability (COS). The purpose of a D-Lactulose CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of D-Lactulose EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of D-Lactulose to their clients by showing that a D-Lactulose CEP has been issued for it. The manufacturer submits a D-Lactulose CEP (COS) as part of the market authorization procedure, and it takes on the role of a D-Lactulose CEP holder for the record. Additionally, the data presented in the D-Lactulose CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the D-Lactulose DMF.
A D-Lactulose CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. D-Lactulose CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of D-Lactulose suppliers with CEP (COS) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing D-Lactulose as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for D-Lactulose API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture D-Lactulose as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain D-Lactulose and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a D-Lactulose NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of D-Lactulose suppliers with NDC on PharmaCompass.
D-Lactulose Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of D-Lactulose GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right D-Lactulose GMP manufacturer or D-Lactulose GMP API supplier for your needs.
A D-Lactulose CoA (Certificate of Analysis) is a formal document that attests to D-Lactulose's compliance with D-Lactulose specifications and serves as a tool for batch-level quality control.
D-Lactulose CoA mostly includes findings from lab analyses of a specific batch. For each D-Lactulose CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
D-Lactulose may be tested according to a variety of international standards, such as European Pharmacopoeia (D-Lactulose EP), D-Lactulose JP (Japanese Pharmacopeia) and the US Pharmacopoeia (D-Lactulose USP).
